Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast

por Boland, G P, Mckeown, A, Chan, K C, Prasad, R, Knox, W F, Bundred, N J
Publicado 2003

PB2022: EXPLORING ALTERNATIVE DOSING REGIMENS OF SINGLE-AGENT BELANTAMAB MAFODOTIN ON SAFETY AND EFFICACY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DREAMM-14

por Hultcrantz, M., Kleinman, D., Ghataorhe, P., Mckeown, A., He, W., Ling, T., Jewell, R. C., Byrne, J., Eliason, L., Scott, E., Opalinska, J.
Publicado 2022